Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

SRPTSarepta Therapeutics, Inc.

Nasdaq · CIK 0000873303
Filer categoryLarge accelerated filer
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts486

Identity from submissions API

NameSarepta Therapeutics, Inc.
CIK0000873303
TickersSRPT
ExchangesNasdaq
Entity typeoperating
CategoryLarge accelerated filer
SIC2834 Pharmaceutical Preparations
EIN930797222
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone617-274-4000
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • Sarepta Therapeutics, Inc. (2012-03-28T00:00:00.000Z → 2026-11-13T00:00:00.000Z)
  • AVI BIOPHARMA INC (1998-11-17T00:00:00.000Z → 2012-07-12T00:00:00.000Z)
  • ANTIVIRALS INC (1997-04-17T00:00:00.000Z → 1998-05-12T00:00:00.000Z)
Business address
215 FIRST STREET
SUITE 415
CAMBRIDGE
MA
02142
MA
Mailing address
215 FIRST STREET
SUITE 415
CAMBRIDGE
MA
02142
MA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

1539 filing rows loaded from submissions recent; extra archives: CIK0000873303-submissions-001.json (536 filings, 1997-01-28 to 2011-03-30).

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-13 13F-HR xslForm13F_X02/primary_doc.xml 0001193125-26-460672 028-26297 261552687 34 4203
2026-11-13 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001167557-26-000255 005-54847 261549236 34 9347
2026-11-10 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000093751-26-000721 005-54847 261538341 34 8398
2026-11-05 8-K 8-K 2.02,9.01 0001193125-26-449822 001-14895 261527383 34 1190527 1 1
2026-11-05 10-Q 10-Q 0001193125-26-449721 001-14895 261527024 34 17704527 1 1
2026-09-23 8-K 8-K 1.01 0001193125-26-399416 001-14895 261401150 34 148176 1 1
2026-09-08 4 4 0001193125-26-385545 5042
2026-09-08 4 4 0001193125-26-385544 5081
2026-09-08 4 4 0001193125-26-385541 4997
2026-09-08 4 4 0001193125-26-385536 5092
2026-08-14 13F-HR xslForm13F_X02/primary_doc.xml 0001193125-26-349827 028-26297 261275515 34 4204
2026-08-13 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001167557-26-000214 005-54847 261272076 34 9279
2026-08-07 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000093751-26-000537 005-54847 261252307 34 9799
2026-08-05 8-K 8-K 2.02,9.01 0001193125-26-335056 001-14895 261243410 34 1081954 1 1
2026-08-05 10-Q 10-Q 0001193125-26-335003 001-14895 261243224 34 16257357 1 1
2026-07-31 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0002100121-26-001000 005-54847 261226751 34 7700
2026-07-30 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0002012383-26-003144 005-54847 261221096 34 11291
2026-07-29 4 4 0001193125-26-324445 7587
2026-07-29 3 3 0001193125-26-324437 17397
2026-07-28 S-8 S-8 0001193125-26-321255 333-297764 261212944 33 193259 1 1
2026-07-27 8-K 8-K 5.02,7.01,9.01 0001193125-26-316995 001-14895 261203035 34 334187 1 1
2026-06-05 4 4 0001193125-26-260263 5145
2026-06-05 4 4 0001193125-26-260261 5142
2026-06-05 4 4 0001193125-26-260259 5170
2026-06-05 4 4 0001193125-26-260257 5839
2026-06-05 4 4 0001193125-26-260255 5175
2026-06-05 4 4 0001193125-26-260250 5152
2026-06-05 4 4 0001193125-26-260246 5857
2026-06-05 4 4 0001193125-26-260245 6510
2026-06-04 S-8 S-8 0001193125-26-257643 333-296501 261065764 33 214543 1 1
2026-06-04 8-K 8-K 5.02,5.07,9.01 0001193125-26-257501 001-14895 261065386 34 327829 1 1
2026-05-13 13F-HR xslForm13F_X02/primary_doc.xml 0001193125-26-221713 028-26297 26973717 34 4204
2026-05-06 8-K 8-K 2.02,9.01 0001193125-26-208966 001-14895 26948446 34 779151 1 1
2026-05-06 10-Q 10-Q 0001193125-26-208893 001-14895 26948158 34 13096495 1 1
2026-04-30 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002100119-26-001050 005-54847 26922629 34 7690
2026-04-29 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002100121-26-000685 005-54847 26914838 34 7636
2026-04-24 ARS ARS 0001193125-26-177347 001-14895 26894405 34 46401927
2026-04-24 DEFA14A DEFA14A 0001193125-26-177258 001-14895 26893903 34 937610
2026-04-24 DEF 14A DEF 14A 0001193125-26-177247 001-14895 26893875 34 9420548 1 1
2026-03-27 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000102909-26-002227 005-54847 26804379 34 7456
2026-03-13 4 4 0001193125-26-106710 4939
2026-03-13 4 4 0001193125-26-106706 4899
2026-03-13 4 4 0001193125-26-106703 4949
2026-03-13 4 4 0001193125-26-106701 4852
2026-03-13 4 4 0001193125-26-106697 4854
2026-03-12 144 xsl144X01/primary_doc.xml 0001950047-26-002538 001-14895 26748179 33 7860
2026-03-11 4 4 0001193125-26-102710 6486
2026-03-11 4 4 0001193125-26-102708 6441
2026-03-11 4 4 0001193125-26-102703 6536
2026-03-11 4 4 0001193125-26-102701 6526
2026-03-03 4 4 0001193125-26-089439 4853
2026-03-03 4 4 0001193125-26-089433 4898
2026-03-03 4 4 0001193125-26-089432 10296
2026-03-03 4 4 0001193125-26-089425 10307
2026-03-02 4 4 0001193125-26-084265 10351
2026-03-02 10-K 10-K 0001193125-26-084144 001-14895 26703415 34 28734369 1 1
2026-02-27 4 4 0001193125-26-083674 5818
2026-02-27 4 4 0001193125-26-083671 5829
2026-02-25 8-K 8-K 5.02 0001193125-26-072064 001-14895 26680093 34 143433 1 1
2026-02-25 8-K 8-K 2.02,9.01 0001193125-26-071566 001-14895 26678639 34 1163834 1 1
2026-02-13 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001167557-26-000049 005-54847 26630270 34 9057
2026-02-13 13F-HR xslForm13F_X02/primary_doc.xml 0001193125-26-049427 028-26297 26628492 34 4250
2026-01-29 4 4 0001193125-26-029895 8318
2026-01-29 4 4 0001193125-26-029893 9006
2026-01-21 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002012383-26-000787 005-54847 26545998 34 11234
2026-01-12 8-K 8-K 2.02,9.01 0001193125-26-010116 001-14895 26525625 34 234529 1 1
2025-12-19 4 4 0001193125-25-326980 9607
2025-12-19 8-K 8-K 1.01,2.03,9.01 0001193125-25-326969 001-14895 251588031 34 190098 1 1
2025-12-18 4 4 0001193125-25-325383 5469
2025-12-16 144 xsl144X01/primary_doc.xml 0001950047-25-010429 001-14895 251576349 33 4945
2025-12-11 8-K 8-K 3.02,8.01,9.01 0001193125-25-315032 001-14895 251563503 34 166778 1 1
2025-12-10 4 4 0001193125-25-314652 6501
2025-12-09 4 4 0001193125-25-313184 11710
2025-12-08 8-K 8-K 5.02,9.01 0001193125-25-310588 001-14895 251554641 34 246301 1 1
2025-12-02 4 4 0001193125-25-305662 4862
2025-11-19 4 4 0001193125-25-288556 4955
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-112507 005-54847 251486039 34 21435
2025-11-10 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000093751-25-000631 005-54847 251464642 34 8289
2025-11-06 10-Q 10-Q 0001193125-25-269436 001-14895 251458069 34 18054699 1 1
2025-11-03 8-K 8-K 2.02,9.01 0001193125-25-262591 001-14895 251444347 34 1096069 1 1
2025-09-08 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000932471-25-001161 005-54847 251299015 34 6502
2025-09-05 4 4 0001193125-25-197425 7125
2025-09-05 4 4 0001193125-25-197424 6880
2025-09-05 4 4 0001193125-25-197423 6919
2025-09-05 4 4 0001193125-25-197422 6835
2025-08-29 8-K 8-K 1.01,2.03,8.01,9.01 0001193125-25-192794 001-14895 251281148 34 923183 1 1
2025-08-21 8-K 8-K 3.02 0001193125-25-184625 001-14895 251238357 34 143652 1 1
2025-08-15 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0000950170-25-109461 185511
2025-08-13 144 xsl144X01/primary_doc.xml 0000950170-25-108325 5306
2025-08-13 8-K 8-K 5.02 0001193125-25-179819 001-14895 251211676 34 134030 1 1
2025-08-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001562230-25-000112 005-54847 251210146 34 7821
2025-08-06 4 4 0000950170-25-104399 5753
2025-08-06 4 4 0000950170-25-104398 5811
2025-08-06 4 4 0000950170-25-104397 5822
2025-08-06 S-8 S-8 0001193125-25-174466 333-289296 251189800 33 209887 1 1
2025-08-06 10-Q 10-Q 0000950170-25-103971 001-14895 251189376 34 15206182 1 1
2025-08-04 4 4 0000950170-25-102279 4895
2025-08-04 3 3 0000950170-25-102276 26835
2025-07-25 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-070926 005-54847 251152782 34 21980
2025-07-25 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-070827 005-54847 251151764 34 17185
2025-07-21 8-K 8-K 8.01 0001193125-25-161516 001-14895 251135713 34 138273 1 1
2025-07-16 8-K 8-K 2.02,2.05,5.02,9.01 0000950170-25-096257 001-14895 251127587 34 284599 1 1
2025-06-06 8-K 8-K 5.02,5.07,9.01 0000950170-25-083131 001-14895 251031171 34 223150 1 1
2025-05-19 4 4 0000950170-25-073954 8010
2025-05-15 4 4 0000950170-25-071961 11390
2025-05-06 10-Q 10-Q 0000950170-25-064412 001-14895 25917086 34 12603103 1 1
2025-04-24 ARS ARS 0000950170-25-058059 001-14895 25867503 34 3058466
2025-04-24 DEFA14A DEFA14A 0000950170-25-058028 001-14895 25867392 34 1230222
2025-04-24 DEF 14A DEF 14A 0000950170-25-058003 001-14895 25867247 34 11809831 1 1
2025-03-13 4 4 0000950170-25-039037 8799
2025-03-12 144 xsl144X01/primary_doc.xml 0001972362-25-000284 001-14895 25732981 33 4513
2025-03-11 4 4 0000950170-25-037533 6952
2025-03-11 4 4 0000950170-25-037532 6911
2025-03-11 4 4 0000950170-25-037531 7624
2025-03-11 4 4 0000950170-25-037527 8995
2025-03-11 4 4 0000950170-25-037519 14351
2025-03-11 4 4 0000950170-25-037526 6937
2025-03-11 4 4 0000950170-25-037525 6909
2025-03-11 4 4 0000950170-25-037524 9021
2025-03-11 4 4 0000950170-25-037523 14358
2025-03-11 4 4 0000950170-25-037516 14309
2025-03-11 4 4 0000950170-25-037514 8317
2025-03-11 4 4 0000950170-25-037522 6920
2025-03-11 4 4 0000950170-25-037511 7605
2025-03-10 4 4 0000950170-25-036695 10259
2025-03-10 4 4 0000950170-25-036694 10267
2025-03-10 4 4 0000950170-25-036693 6426
2025-03-10 4 4 0000950170-25-036692 10218
2025-03-10 4 4 0000950170-25-036691 10209
2025-03-06 4 4 0000950170-25-035006 6266
2025-03-06 4 4 0000950170-25-035005 6292
2025-03-06 4 4 0000950170-25-035004 4893
2025-03-06 4 4 0000950170-25-035003 4934
2025-03-06 4 4 0000950170-25-035002 4942
2025-03-04 4 4 0000950170-25-032762 5123
2025-03-04 4 4 0000950170-25-032761 5114
2025-03-04 4 4 0000950170-25-032760 4933
2025-03-04 4 4 0000950170-25-032759 5172
2025-03-04 4 4 0000950170-25-032758 5088
2025-03-03 S-3ASR S-3ASR 0001193125-25-044088 333-285491 25697647 33 604615 1 1
2025-02-28 10-K 10-K 0000950170-25-029973 001-14895 25689866 34 26896115 1 1
2025-02-26 8-K 8-K 2.02,9.01 0000950170-25-027717 001-14895 25669963 34 1028947 1 1
2025-02-14 SCHEDULE 13D xslSCHEDULE_13D_X01/primary_doc.xml 0000950170-25-021481 980564
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001562230-25-000046 005-54847 25626237 34 7849
2025-02-14 8-K 8-K 1.01,2.03,9.01 0001193125-25-026683 001-14895 25623505 34 1337627 1 1
2025-02-13 4 4 0000950170-25-020194 5830
2025-02-13 4 4 0000950170-25-020193 5835
2025-02-13 4 4 0000950170-25-020192 5828
2025-02-13 4 4 0000950170-25-020191 5777
2025-01-31 4 4 0000950170-25-011959 11805
2025-01-13 8-K 8-K 2.02,9.01 0001193125-25-005160 001-14895 25525566 34 198369 1 1
2024-12-30 4 4 0000950170-24-141250 4829
2024-12-16 4 4 0000950170-24-136847 8595
2024-12-12 144 xsl144X01/primary_doc.xml 0001972362-24-001860 001-14895 241545791 33 4550
2024-12-06 4 4 0000950170-24-134285 4861
2024-12-05 144 xsl144X01/primary_doc.xml 0001972362-24-001811 001-14895 241529342 33 4507
2024-11-29 4 4 0000950170-24-131938 7441
2024-11-29 3 3 0000950170-24-131937 13499
2024-11-26 8-K 8-K 1.01 0001193125-24-265627 001-14895 241498152 34 159854 1 1
2024-11-20 4 4 0000950170-24-129454 5172
2024-11-14 SC 13G/A JANUS CLOSEOUT 0001274173-24-000085 005-54847 241457866 34 10418
2024-11-13 SC 13G/A SEC SCHEDULE 13G 0001562230-24-000064 005-54847 241451810 34 18522
2024-11-06 10-Q 10-Q 0000950170-24-122239 001-14895 241430778 34 12811126 1 1
2024-09-16 4 4 0000950170-24-106954 7173
2024-09-16 3 3 0000950170-24-106953 14471
2024-09-16 8-K 8-K 5.02,5.03,9.01 0000950170-24-106619 001-14895 241299451 34 165352 1 1
2024-09-05 4 4 0000950170-24-104194 5439
2024-09-03 4 4 0000950170-24-103070 4968
2024-08-30 144 xsl144X01/primary_doc.xml 0001972362-24-001277 001-14895 241270947 33 7296
2024-08-20 4 4 0000950170-24-098859 9901
2024-08-07 S-8 S-8 0001193125-24-195944 333-281334 241184615 33 232389 1 1
2024-08-07 10-Q 10-Q 0000950170-24-092720 001-14895 241183456 34 11942784 1 1
2024-07-08 4 4 0000950170-24-082240 7335
2024-06-25 4 4 0000950170-24-077522 29822
2024-06-25 4 4 0000950170-24-077521 13344
2024-06-25 4 4 0000950170-24-077520 13295
2024-06-25 4 4 0000950170-24-077519 13336
2024-06-25 4 4 0000950170-24-077518 22032
2024-06-25 144 xsl144X01/primary_doc.xml 0001950047-24-005024 001-14895 241069393 33 5720
2024-06-25 144 xsl144X01/primary_doc.xml 0001950047-24-005009 001-14895 241069167 33 6374
2024-06-24 144 xsl144X01/primary_doc.xml 0001950047-24-004980 001-14895 241064505 33 5758
2024-06-07 8-K 8-K 5.02,5.07,9.01 0001193125-24-157458 001-14895 241030301 34 168137 1 1
2024-06-07 SC 13G/A us8036071004_060724.txt 0001086364-24-007807 005-54847 241028559 34 14085
2024-05-06 4 4 0000950170-24-053837 4863
2024-05-06 3 3 0000950170-24-053831 36957
2024-05-01 10-Q 10-Q 0000950170-24-051234 001-14895 24902839 34 10396544 1 1
2024-04-24 DEF 14A DEF 14A 0000950170-24-047570 001-14895 24870549 34 5048833 1 1
2024-04-24 ARS ARS 0000950170-24-047561 001-14895 24870498 34 1102132
2024-04-24 DEFA14A DEFA14A 0000950170-24-047559 001-14895 24870483 34 1131072
2024-03-28 S-8 POS S-8 POS 0001193125-24-080645 333-209710 24799185 33 225031
2024-03-28 S-8 POS S-8 POS 0001193125-24-080636 333-221271 24799142 33 225031
2024-03-28 S-8 POS S-8 POS 0001193125-24-080633 333-228719 24799117 33 225031
2024-03-28 S-8 POS S-8 POS 0001193125-24-080624 333-240996 24799051 33 225031
2024-03-11 4 4 0000950170-24-029536 11856
2024-03-11 4 4 0000950170-24-029533 6465
2024-03-11 4 4 0000950170-24-029532 6523
2024-03-11 4 4 0000950170-24-029531 4852
2024-03-11 4 4 0000950170-24-029530 6471
2024-03-11 4 4 0000950170-24-029529 6516
2024-03-11 144 xsl144X01/primary_doc.xml 0001972362-24-000392 001-14895 24739692 33 4502
2024-03-08 144 xsl144X01/primary_doc.xml 0001972362-24-000374 001-14895 24735786 33 4549
2024-03-06 4 4 0000950170-24-027498 4928
2024-03-06 4 4 0000950170-24-027497 4851
2024-03-06 4 4 0000950170-24-027495 4884
2024-03-06 4 4 0000950170-24-027494 6286
2024-03-06 4 4 0000950170-24-027496 4936
2024-03-05 4 4 0000950170-24-026617 6949
2024-03-05 4 4 0000950170-24-026614 6938
2024-03-05 4 4 0000950170-24-026619 6967
2024-03-05 4 4 0000950170-24-026618 7636
2024-03-05 4 4 0000950170-24-026613 7653
2024-03-05 4 4 0000950170-24-026606 13939
2024-03-05 4 4 0000950170-24-026616 6941
2024-03-05 4 4 0000950170-24-026605 10711
2024-03-05 4 4 0000950170-24-026615 8310
2024-03-05 4 4 0000950170-24-026609 10667
2024-03-05 4 4 0000950170-24-026607 9345
2024-03-05 144 xsl144X01/primary_doc.xml 0001972362-24-000325 001-14895 24722619 33 5028
2024-03-01 144 xsl144X01/primary_doc.xml 0001972362-24-000284 001-14895 24712436 33 5055
2024-03-01 144 xsl144X01/primary_doc.xml 0001972362-24-000274 001-14895 24712372 33 5016
2024-03-01 144 xsl144X01/primary_doc.xml 0001950047-24-001704 001-14895 24710806 33 6778
2024-02-28 10-K 10-K 0000950170-24-022036 001-14895 24695048 34 19223364 1 1
2024-02-13 SC 13G/A SCHEDULE 13G/A 0001104659-24-021893 005-54847 24629490 34 13350
2024-02-13 SC 13G/A JHG PLC OWNS >5% 0001274173-24-000037 005-54847 24624347 34 10797
2024-02-09 SC 13G SEC SCHEDULE 13G 0001422848-24-000171 005-54847 24616648 34 18724
2024-01-26 SC 13G/A us8036071004_012624.txt 0001086364-24-004894 005-54847 24569235 34 14053
2024-01-08 8-K 8-K 2.02,7.01,9.01 0000950170-24-002822 001-14895 24519128 34 243773 1 1
2023-12-05 4 FORM 4 SUBMISSION 0001209191-23-057558 5257
2023-11-20 4 FORM 4 SUBMISSION 0001209191-23-056168 5300
2023-11-06 4 FORM 4 SUBMISSION 0001209191-23-054442 7658
2023-11-06 4 FORM 4 SUBMISSION 0001209191-23-054441 10974
2023-11-06 4 FORM 4 SUBMISSION 0001209191-23-054440 7675
2023-11-01 10-Q 10-Q 0000950170-23-057414 001-14895 231368098 34 14193107 1 1
2023-08-15 4 FORM 4 SUBMISSION 0001209191-23-045766 8179
2023-08-14 4 FORM 4 SUBMISSION 0001209191-23-045498 6004
2023-08-11 4 FORM 4 SUBMISSION 0001209191-23-045366 10356
2023-08-08 4 FORM 4 SUBMISSION 0001209191-23-045095 9053
2023-08-04 144 xsl144X01/primary_doc.xml 0001972362-23-000578 001-14895 231145250 33 4387
2023-08-02 S-8 S-8 0001193125-23-201740 333-273608 231135931 33 70204
2023-08-02 10-Q 10-Q 0000950170-23-037125 001-14895 231135424 34 16215084 1 1
2023-06-22 8-K 8-K 7.01,9.01 0000950170-23-029438 001-14895 231033948 34 8519617 1 1
2023-06-22 8-K 8-K 7.01,9.01 0000950170-23-029354 001-14895 231032927 34 409056 1 1
2023-06-09 8-K 8-K 5.02,5.07,9.01 0000950170-23-027276 001-14895 231005727 34 312002 1 1
2023-06-05 4 FORM 4 SUBMISSION 0001209191-23-034676 5022
2023-05-02 10-Q 10-Q 0000950170-23-016654 001-14895 23878790 34 12120535 1 1
2023-04-24 DEFA14A DEFA14A 0000950170-23-014092 001-14895 23840306 34 1286844
2023-04-24 ARS ARS 0000950170-23-014087 001-14895 23840220 34 11976147
2023-04-24 DEF 14A DEF 14A 0000950170-23-014085 001-14895 23840158 34 8959280 1 1
2023-04-04 4 FORM 4 SUBMISSION 0001209191-23-023064 5028
2023-03-10 4 FORM 4 SUBMISSION 0001209191-23-018021 5039
2023-03-10 4 FORM 4 SUBMISSION 0001209191-23-018020 5036
2023-03-10 4 FORM 4 SUBMISSION 0001209191-23-018019 4992
2023-03-10 4 FORM 4 SUBMISSION 0001209191-23-018018 4995
2023-03-08 4 FORM 4 SUBMISSION 0001209191-23-017404 7246
2023-03-08 4 FORM 4 SUBMISSION 0001209191-23-017403 11056
2023-03-08 4 FORM 4 SUBMISSION 0001209191-23-017408 9532
2023-03-08 4 FORM 4 SUBMISSION 0001209191-23-017402 7915
2023-03-08 4 FORM 4 SUBMISSION 0001209191-23-017407 9535
2023-03-08 4 FORM 4 SUBMISSION 0001209191-23-017401 7906
2023-03-08 4 FORM 4 SUBMISSION 0001209191-23-017400 11237
2023-03-08 4 FORM 4 SUBMISSION 0001209191-23-017406 7931
2023-03-08 4 FORM 4 SUBMISSION 0001209191-23-017405 7228
2023-03-08 4 FORM 4 SUBMISSION 0001209191-23-017399 7219
2023-03-08 4 FORM 4 SUBMISSION 0001209191-23-017394 7201
2023-03-03 4 FORM 4 SUBMISSION 0001209191-23-016058 6795
2023-03-03 4 FORM 4 SUBMISSION 0001209191-23-016057 4992
2023-03-03 4 FORM 4 SUBMISSION 0001209191-23-016055 5040
2023-03-03 4 FORM 4 SUBMISSION 0001209191-23-016054 5274
2023-03-03 8-K 8-K 1.01,3.02,9.01 0001193125-23-058990 001-14895 23701639 34 264295 1 1
2023-02-28 10-K 10-K 0000950170-23-005062 001-14895 23685081 34 24706024 1 1
2023-02-14 SC 13G/A 13ga1_sarepta.htm 0001175707-23-000084 005-54847 23627875 34 75554
2023-02-10 SC 13G/A JHG PLC OWNS >5% 0001274173-23-000047 005-54847 23609515 34 10709
2023-02-09 SC 13G/A SCHEDULE 13G/A 0001104659-23-016902 005-54847 23604179 34 13268
2023-02-01 SC 13G/A us8036071004_013123.txt 0001306550-23-005971 005-54847 23573951 34 13737
2023-01-09 8-K 8-K 2.02,7.01,9.01 0000950170-23-000495 001-14895 23517564 34 10967119 1 1
2023-01-04 4 FORM 4 SUBMISSION 0001209191-23-001464 5413
2023-01-04 3 FORM 3 SUBMISSION 0001209191-23-001462 14712
2022-12-21 4 FORM 4 SUBMISSION 0001209191-22-062287 7643
2022-12-13 8-K 8-K 5.03,9.01 0001193125-22-303900 001-14895 221460410 34 318226 1 1
2022-11-21 4 FORM 4 SUBMISSION 0001209191-22-058284 5273
2022-11-21 4 FORM 4 SUBMISSION 0001209191-22-058283 4951
2022-11-02 8-K 8-K 5.02 0001193125-22-275897 001-14895 221355040 34 142379 1 1
2022-11-02 10-Q 10-Q 0000950170-22-021213 001-14895 221353948 34 14817799 1 1
2022-09-19 8-K 8-K 1.01,1.02,2.03,3.02,8.01,9.01 0001193125-22-247130 001-14895 221250935 34 4451350 1 1
2022-09-15 4 FORM 4 SUBMISSION 0001209191-22-050002 10086
2022-09-14 4 FORM 4 SUBMISSION 0001209191-22-049820 6776
2022-08-22 4 FORM 4 SUBMISSION 0001209191-22-046973 8030
2022-08-02 S-8 S-8 0001193125-22-210023 333-266461 221128881 33 59157
2022-08-02 10-Q 10-Q 0000950170-22-013863 001-14895 221128596 34 12420217 1 1
2022-06-06 4 FORM 4 SUBMISSION 0001209191-22-034740 7397
2022-06-06 4 FORM 4 SUBMISSION 0001209191-22-034739 8115
2022-06-06 3 FORM 3 SUBMISSION 0001209191-22-034738 8368
2022-06-06 3 FORM 3 SUBMISSION 0001209191-22-034734 7562
2022-06-03 4 FORM 4 SUBMISSION 0001209191-22-034380 4992
2022-06-03 8-K 8-K 5.02,5.07,9.01 0000950170-22-011164 001-14895 22994734 34 260237 1 1
2022-05-04 10-Q 10-Q 0000950170-22-007375 001-14895 22891474 34 10472180 1 1
2022-04-25 DEF 14A DEF 14A 0001564590-22-015429 001-14895 22849922 34 4914486
2022-04-21 8-K 8-K 5.02,9.01 0001193125-22-112139 001-14895 22839704 34 209952 1 1
2022-04-05 8-K FORM 8-K 5.02 0000950170-22-005381 001-14895 22809095 34 163174 1 1
2022-03-09 4 FORM 4 SUBMISSION 0001209191-22-017713 7200
2022-03-08 4 FORM 4 SUBMISSION 0001209191-22-017353 7227
2022-03-08 4 FORM 4 SUBMISSION 0001209191-22-017352 7209
2022-03-08 4 FORM 4 SUBMISSION 0001209191-22-017350 7245
2022-03-08 4 FORM 4 SUBMISSION 0001209191-22-017349 7914
2022-03-08 4 FORM 4 SUBMISSION 0001209191-22-017348 7905
2022-03-08 4 FORM 4 SUBMISSION 0001209191-22-017347 11274
2022-03-08 4 FORM 4 SUBMISSION 0001209191-22-017346 11237
2022-03-08 4 FORM 4 SUBMISSION 0001209191-22-017345 9922
2022-03-08 4 FORM 4 SUBMISSION 0001209191-22-017343 9533
2022-03-02 S-3ASR S-3ASR 0001193125-22-062344 333-263208 22701448 33 448184
2022-03-01 4 FORM 4 SUBMISSION 0001209191-22-014409 5328
2022-03-01 4 FORM 4 SUBMISSION 0001209191-22-014408 5034
2022-03-01 4 FORM 4 SUBMISSION 0001209191-22-014407 4995
2022-03-01 10-K 10-K 0000950170-22-002517 001-14895 22697866 34 21696725 1 1
2022-02-14 SC 13G SC 13G 0001140361-22-004974 005-54847 22623762 34 11217
2022-02-11 SC 13G JANUS HENDERSON GROUP PLC OWNS >5% 0001274173-22-000060 005-54847 22618385 34 10816
2022-02-10 SC 13G/A SCHEDULE 13G/A 0001104659-22-018511 005-54847 22610785 34 13263
2022-02-09 SC 13G/A filing.txt 0000315066-22-001337 005-54847 22604833 34 8750
2022-02-01 SC 13G/A us8036071004_020122.txt 0000834237-22-004614 005-54847 22580108 34 13861
2022-01-10 8-K 8-K 2.02,7.01,9.01 0000950170-22-000205 001-14895 22520244 34 2406220 1 1
2021-12-16 4 FORM 4 SUBMISSION 0001209191-21-070084 7637
2021-12-14 4 FORM 4 SUBMISSION 0001209191-21-069638 7307
2021-11-29 4 FORM 4 SUBMISSION 0001209191-21-066948 4810
2021-11-17 4 FORM 4 SUBMISSION 0001209191-21-065315 7393
2021-11-17 4 FORM 4 SUBMISSION 0001209191-21-065314 5598
2021-11-17 3 FORM 3 SUBMISSION 0001209191-21-065313 7776
2021-11-17 4 FORM 4 SUBMISSION 0001209191-21-065246 5319
2021-11-17 8-K 8-K 5.02 0000950170-21-004713 001-14895 211418483 34 169479 1 1
2021-11-03 10-Q 10-Q 0000950170-21-002815 001-14895 211375289 34 12862379 1 1
2021-10-15 8-K 8-K 1.01,2.02,8.01,9.01 0001193125-21-300047 001-14895 211326258 34 482416 1 1
2021-10-15 424B5 424B5 0001193125-21-300033 333-229934 211326211 33 432656
2021-10-12 424B5 424B5 0001193125-21-296879 333-229934 211318664 33 420204
2021-09-27 8-K 8-K 7.01,9.01 0001564590-21-048961 001-14895 211279050 34 227809 1 1
2021-09-09 4 FORM 4 SUBMISSION 0001209191-21-055383 5004
2021-08-10 SC 13G/A SEC SCHEDULE 13G 0001422848-21-000157 005-54847 211159138 34 18503
2021-08-04 10-Q SRPT Q2 2021 10-Q 0001564590-21-040787 001-14895 211143929 34 11840188 1 1
2021-06-28 4 FORM 4 SUBMISSION 0001209191-21-043582 5104
2021-06-03 8-K 8-K 5.07 0001564590-21-031601 001-14895 21993305 34 200005 1 1
2021-06-03 4 FORM 4 SUBMISSION 0001209191-21-037727 4985
2021-05-18 8-K 8-K 7.01,9.01 0001564590-21-028550 001-14895 21934024 34 5804456 1 1
2021-05-05 10-Q SRPT Q1 2021 10-Q 0001564590-21-024018 001-14895 21893108 34 10048532 1 1
2021-05-03 8-K 8-K 7.01,9.01 0001564590-21-022707 001-14895 21881577 34 8528000 1 1
2021-04-20 DEFA14A DEFA14A 0001564590-21-019636 001-14895 21838025 34 357507
2021-04-20 DEF 14A DEF 14A 0001564590-21-019631 001-14895 21837944 34 4965962
2021-03-10 4 FORM 4 SUBMISSION 0001209191-21-019671 9161
2021-03-10 4 FORM 4 SUBMISSION 0001209191-21-019670 8974
2021-03-10 4/A FORM 4/A SUBMISSION 0001209191-21-019668 7226
2021-03-10 4/A FORM 4/A SUBMISSION 0001209191-21-019667 8941
2021-03-10 4/A FORM 4/A SUBMISSION 0001209191-21-019666 7534
2021-03-10 4/A FORM 4/A SUBMISSION 0001209191-21-019664 8984
2021-03-05 4 FORM 4 SUBMISSION 0001209191-21-018423 7245
2021-03-05 4 FORM 4 SUBMISSION 0001209191-21-018421 7855
2021-03-05 4 FORM 4 SUBMISSION 0001209191-21-018420 7833
2021-03-05 4 FORM 4 SUBMISSION 0001209191-21-018419 7224
2021-03-05 4 FORM 4 SUBMISSION 0001209191-21-018418 7217
2021-03-05 4 FORM 4 SUBMISSION 0001209191-21-018417 7208
2021-03-05 4 FORM 4 SUBMISSION 0001209191-21-018416 7842
2021-03-05 4 FORM 4 SUBMISSION 0001209191-21-018415 7834
2021-03-05 4 FORM 4 SUBMISSION 0001209191-21-018414 7800
2021-03-05 4 FORM 4 SUBMISSION 0001209191-21-018413 7219
2021-03-05 4 FORM 4 SUBMISSION 0001209191-21-018412 8215
2021-03-05 3 FORM 3 SUBMISSION 0001209191-21-018410 10331
2021-03-01 10-K SRPT 12/31/2020 10-K 0001564590-21-009835 001-14895 21697621 34 23413269 1 1
2021-02-16 SC 13G srpt12312020.txt 0001020066-21-000014 005-54847 21634520 34 10790
2021-02-12 5 FORM 5 SUBMISSION 0001209191-21-010478 4954
2021-02-10 SC 13G/A SEC SCHEDULE 13G 0001422848-21-000005 005-54847 21612587 34 18474
2021-02-10 SC 13G SEC SCHEDULE 13G 0001422848-21-000004 005-54847 21612569 34 18464
2021-02-10 SC 13G/A SCHEDULE 13G/A 0001104659-21-019035 005-54847 21611881 34 14124
2021-02-08 SC 13G/A filing.txt 0000315066-21-001226 005-54847 21599762 34 8735
2021-02-01 SC 13G/A us8036071004_013121.txt 0000834237-21-005501 005-54847 21574525 34 13892
2021-01-11 8-K 8-K 2.02,7.01,9.01 0001564590-21-000783 001-14895 21519716 34 2344752 1 1
2021-01-07 8-K 8-K 7.01,9.01 0001564590-21-000577 001-14895 21514823 34 1422292 1 1
2021-01-04 4 FORM 4 SUBMISSION 0001209191-21-000556 5068
2020-12-14 4 FORM 4 SUBMISSION 0001209191-20-063360 5883
2020-12-14 4 FORM 4 SUBMISSION 0001209191-20-063359 5879
2020-12-14 3 FORM 3 SUBMISSION 0001209191-20-063358 10350
2020-12-14 3 FORM 3 SUBMISSION 0001209191-20-063357 16590
2020-12-14 4 FORM 4 SUBMISSION 0001209191-20-063355 8882
2020-12-14 8-K 8-K 5.02 0001564590-20-056951 001-14895 201385215 34 167046 1 1
2020-12-10 4 FORM 4 SUBMISSION 0001209191-20-062809 7320
2020-12-10 4 FORM 4 SUBMISSION 0001209191-20-062807 9156
2020-11-05 10-Q Q3 2020 10-Q 0001564590-20-051308 001-14895 201290504 34 11492633 1 1
2020-09-25 8-K 8-K 1.01,2.03 0001564590-20-044684 001-14895 201200871 34 166871 1 1
2020-09-09 8-K 8-K 7.01,9.01 0001564590-20-043013 001-14895 201167173 34 193905 1 1
2020-08-11 4 FORM 4 SUBMISSION 0001209191-20-046251 11003
2020-08-07 4 FORM 4 SUBMISSION 0001209191-20-045774 7222
2020-08-05 4 FORM 4 SUBMISSION 0001209191-20-045321 8927
2020-08-05 3 FORM 3 SUBMISSION 0001209191-20-045320 8309
2020-08-05 S-8 S-8 0001564590-20-036860 333-240996 201078080 33 155064
2020-08-05 10-Q Q2 2020 10-Q 0001564590-20-036794 001-14895 201077273 34 10985850 1 1
2020-08-05 8-K 8-K 5.02 0001564590-20-036775 001-14895 201077138 34 162943 1 1
2020-07-09 4 FORM 4 SUBMISSION 0001209191-20-042060 16830
2020-06-30 8-K 8-K 5.02 0001564590-20-031151 001-14895 201000517 34 162662 1 1
2020-06-22 4 FORM 4 SUBMISSION 0001209191-20-038339 26822
2020-06-08 8-K 8-K 5.02,5.03,5.07,9.01 0001564590-20-028562 001-14895 20948247 34 246376 1 1
2020-06-08 8-K 8-K 7.01,9.01 0001564590-20-028560 001-14895 20948232 34 14195960 1 1
2020-05-22 4 FORM 4 SUBMISSION 0001209191-20-031881 12999
2020-05-15 4 FORM 4 SUBMISSION 0001209191-20-029918 7221
2020-05-06 10-Q Q1 2020 10-Q 0001564590-20-021905 001-14895 20852541 34 9294187 1 1
2020-04-21 DEFA14A DEFA14A 0001564590-20-017704 001-14895 20805474 34 273398

Latest XBRL company facts

One latest value per concept from companyfacts (486 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 107.24M 2026-11-02 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
dei EntityPublicFloat Entity Public Float USD 1.67B 2025-06-30 2025 FY 10-K 2026-03-02 0001193125-26-084144
ecd CoSelectedMeasureAmt CoSelectedMeasureAmt USD 1.86B 2025-01-01 2025-12-31 DEF 14A 2026-04-24 0001193125-26-177247
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 1.16M 2025-01-01 2025-12-31 DEF 14A 2026-04-24 0001193125-26-177247
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 3.82M 2025-01-01 2025-12-31 DEF 14A 2026-04-24 0001193125-26-177247
ecd PeerGroupTotalShareholderRtnAmt PeerGroupTotalShareholderRtnAmt USD 124.8 2025-01-01 2025-12-31 DEF 14A 2026-04-24 0001193125-26-177247
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD -17.29M 2025-01-01 2025-12-31 DEF 14A 2026-04-24 0001193125-26-177247
ecd PeoTotalCompAmt PeoTotalCompAmt USD 7.84M 2025-01-01 2025-12-31 DEF 14A 2026-04-24 0001193125-26-177247
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 12.62 2025-01-01 2025-12-31 DEF 14A 2026-04-24 0001193125-26-177247
ffd NetFeeAmt NetFeeAmt USD 5,430.79 2026-07-28 S-8 2026-07-28 0001193125-26-321255
ffd TtlFeeAmt TtlFeeAmt USD 5,430.79 2026-07-28 S-8 2026-07-28 0001193125-26-321255
ffd TtlOfferingAmt TtlOfferingAmt USD 39.33M 2026-07-28 S-8 2026-07-28 0001193125-26-321255
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-07-28 S-8 2026-07-28 0001193125-26-321255
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 45.70M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 369.18M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 5.12M 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-10-31 0001564590-18-025831
us-gaap AccruedEmployeeBenefitsCurrent Accrued Employee Benefits, Current USD 5.00M 2013-12-31 2014 FY 10-K 2015-02-26 0001193125-15-063997
us-gaap AccruedIncomeTaxes Accrued Income Taxes USD 10.22M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap AccruedIncomeTaxesCurrent Accrued Income Taxes, Current USD 301,000 2018-12-31 2018 FY 10-K 2019-02-28 0001564590-19-005170
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 321.76M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap AccruedMarketingCostsCurrent Accrued Marketing Costs, Current USD 3.52M 2023-09-30 2023 Q3 10-Q 2023-11-01 0000950170-23-057414
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 22.02M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap AccruedRoyaltiesCurrent Accrued Royalties, Current USD 9.43M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 280.47M 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -1.59M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap AcquisitionCosts Acquisition Costs, Period Cost USD 2.39M 1980-07-22 2013-03-31 2013 Q1 10-Q 2013-05-09 0001193125-13-211458
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 947.83M 2015-06-30 2015 Q2 10-Q 2015-08-06 0001193125-15-279829
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 6.13B 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation Share-based Payment Arrangement, Decrease for Tax Withholding Obligation USD 1.43M 2021-01-01 2021-12-31 2023 FY 10-K 2024-02-28 0000950170-24-022036
us-gaap AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt USD 156.95M 2017-01-01 2017-12-31 2019 FY 10-K 2020-02-26 0001564590-20-006769
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition USD 30.29M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap AdvertisingExpense Advertising Expense USD 29.50M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 80.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap AllocatedShareBasedCompensationExpenseNetOfTax Share-based Payment Arrangement, Expense, after Tax USD 91.99M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap AllowanceForDoubtfulAccountsReceivableCurrent Accounts Receivable, Allowance for Credit Loss, Current USD 169.67M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD 2.43M 2014-01-01 2014-12-31 2014 FY 10-K 2015-02-26 0001193125-15-063997
us-gaap AmortizationOfFinancingCosts Amortization of Debt Issuance Costs USD 12.10M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 2.13M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 26.08M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap Assets Assets USD 3.17B 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap AssetsCurrent Assets, Current USD 2.27B 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 735.42M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap AssetsHeldForSaleLongLived Assets Held-for-sale, Long Lived (Deprecated 2014-01-31) USD 1.97M 2010-12-31 2011 FY 10-K 2012-03-13 0001193125-12-112142
us-gaap AssetsHeldForSaleNotPartOfDisposalGroupCurrent Assets Held-for-sale, Not Part of Disposal Group, Current USD 1.50M 2017-12-31 2018 FY 10-K 2019-02-28 0001564590-19-005170
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 294,000 2024-12-31 2024 FY 10-K 2025-02-28 0000950170-25-029973
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 485,000 2024-12-31 2024 FY 10-K 2025-02-28 0000950170-25-029973
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 1.08B 2024-06-30 2024 Q2 10-Q 2024-08-07 0000950170-24-092720
us-gaap AvailableForSaleSecurities Available-for-sale Securities USD 792.86M 2018-09-30 2018 Q3 10-Q 2018-10-31 0001564590-18-025831
us-gaap AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax USD 213,000 2018-09-30 2018 Q3 10-Q 2018-10-31 0001564590-18-025831
us-gaap AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax USD 205,000 2018-09-30 2018 Q3 10-Q 2018-10-31 0001564590-18-025831
us-gaap AvailableForSaleSecuritiesAmortizedCost Available-for-sale Securities, Amortized Cost Basis USD 792.85M 2018-09-30 2018 Q3 10-Q 2018-10-31 0001564590-18-025831
us-gaap AvailableForSaleSecuritiesDebtSecuritiesCurrent Debt Securities, Available-for-sale, Current USD 1.08B 2024-06-30 2024 Q2 10-Q 2024-08-07 0000950170-24-092720
us-gaap AvailableForSaleSecuritiesDebtSecuritiesNoncurrent Debt Securities, Available-for-sale, Noncurrent USD 428.43M 2023-12-31 2023 FY 10-K 2024-02-28 0000950170-24-022036
us-gaap AvailableForSaleSecuritiesGrossRealizedGains Available-for-sale Securities, Gross Realized Gains USD 3.86M 1980-07-22 2014-03-31 2014 Q1 10-Q 2014-05-08 0001193125-14-188608
us-gaap AvailableForSaleSecuritiesGrossUnrealizedGains Available-for-sale Securities, Gross Unrealized Gain USD 0 2015-01-01 2015-06-30 2015 Q2 10-Q 2015-08-06 0001193125-15-279829
us-gaap AvailableForSaleSecuritiesGrossUnrealizedLoss Available-for-sale Securities, Gross Unrealized Loss USD 2,000 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-05 0001564590-15-009495
us-gaap AvailableForSaleSecuritiesNoncurrent Available-for-sale Securities, Noncurrent USD 9.98M 2017-12-31 2018 Q3 10-Q 2018-10-31 0001564590-18-025831
us-gaap AvailableForSaleSecuritiesTransfersToTradingGrossGains Available-for-sale Securities, Transfers to Trading, Gross Gains USD 108.07M 2020-01-01 2020-03-31 2021 Q1 10-Q 2021-05-05 0001564590-21-024018
us-gaap BilledContractReceivables Billed Contracts Receivable USD 369.20M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability USD 600,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-01 0000950170-22-002517
us-gaap BusinessCombinationContingentConsiderationLiability Business Combination, Contingent Consideration, Liability USD 47.40M 2025-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap BusinessCombinationContingentConsiderationLiabilityCurrent Business Combination, Contingent Consideration, Liability, Current USD 36.00M 2025-09-30 2025 Q3 10-Q 2025-11-06 0001193125-25-269436
us-gaap BusinessCombinationContingentConsiderationLiabilityNoncurrent Business Combination, Contingent Consideration, Liability, Noncurrent USD 0 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 472.76M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD 495.21M 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-01 0001564590-17-020808
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 1.69B 2023-12-31 2023 FY 10-K 2024-02-28 0000950170-24-022036
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 482.88M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 814.41M 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -331.52M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 215.92M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1 Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 0 2014-12-31 2014 FY 10-K 2015-02-26 0001193125-15-063997
us-gaap CommitmentsAndContingencies Commitments and Contingencies USD 0 2012-06-30 2012 Q2 10-Q 2012-08-07 0001193125-12-340912
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 198.00M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 107.89M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 107.23M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap CommonStockValue Common Stock, Value, Issued USD 11,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD 295.75M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap ConstructionInProgressGross Construction in Progress, Gross USD 11.30M 2013-12-31 2014 Q1 10-Q 2014-05-08 0001193125-14-188608
us-gaap ContractsRevenue Contracts Revenue (Deprecated 2018-01-31) USD 1.25M 2015-01-01 2015-12-31 2017 FY 10-K 2018-03-01 0001564590-18-004107
us-gaap ContractualObligation Contractual Obligation USD 354.08M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap ContractualObligationDueAfterFifthYear Contractual Obligation, to be Paid, after Year Five USD 0 2023-12-31 2023 FY 10-K 2024-02-28 0000950170-24-022036
us-gaap ContractualObligationDueInFifthYear Contractual Obligation, to be Paid, Year Five USD 72.28M 2023-12-31 2023 FY 10-K 2024-02-28 0000950170-24-022036
us-gaap ContractualObligationDueInFourthYear Contractual Obligation, to be Paid, Year Four USD 72.34M 2024-12-31 2024 FY 10-K 2025-02-28 0000950170-25-029973
us-gaap ContractualObligationDueInNextTwelveMonths Contractual Obligation, to be Paid, Year One USD 145.45M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap ContractualObligationDueInSecondYear Contractual Obligation, to be Paid, Year Two USD 39.64M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap ContractualObligationDueInThirdYear Contractual Obligation, to be Paid, Year Three USD 23.43M 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear Contractual Obligation, to be Paid, Remainder of Fiscal Year USD 168.99M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap ContractWithCustomerLiability Contract with Customer, Liability USD 3.30M 2018-12-31 2018 FY 10-K 2019-02-28 0001564590-19-005170
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 104.89M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap ContractWithCustomerLiabilityNoncurrent Contract with Customer, Liability, Noncurrent USD 83.91M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap ConvertibleDebtFairValueDisclosures Convertible Debt, Fair Value Disclosures USD 952.68M 2018-12-31 2018 FY 10-K 2019-02-28 0001564590-19-005170
us-gaap CostOfGoodsSold Cost of Goods Sold (Deprecated 2018-01-31) USD 786,000 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-08-03 0001564590-17-015393
us-gaap CostOfRevenue Cost of Revenue USD 25.50M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap CostsAndExpenses Costs and Expenses USD 1.15B 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap CurrentFederalStateAndLocalTaxExpenseBenefit Current Federal, State and Local, Tax Expense (Benefit) USD 4.20M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-28 0000950170-24-022036
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD -1.27M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap CurrentForeignTaxExpenseBenefit Current Foreign Tax Expense (Benefit) USD 1.38M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 11.55M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 11.44M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap DebtConversionConvertedInstrumentAmount1 Debt Conversion, Converted Instrument, Amount USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap DebtInstrumentConvertibleConversionRatio1 Debt Instrument, Convertible, Conversion Ratio pure 0.014 2017-11-13 2017-11-14 2022 Q3 10-Q 2022-11-02 0000950170-22-021213
us-gaap DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger pure 0.98 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap DebtInstrumentFaceAmount Debt Instrument, Face Amount USD 1.27B 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap DebtInstrumentFairValue Debt Instrument, Fair Value Disclosure USD 904.11M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap DebtInstrumentInterestRateStatedPercentage Debt Instrument, Interest Rate, Stated Percentage pure 0.048 2014-12-31 2014 FY 10-K 2015-02-26 0001193125-15-063997
us-gaap DebtInstrumentUnamortizedDiscount Debt Instrument, Unamortized Discount USD 0 2022-12-31 2022 FY 10-K 2023-02-28 0000950170-23-005062
us-gaap DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap DeferredForeignIncomeTaxExpenseBenefit Deferred Foreign Income Tax Expense (Benefit) USD -363,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD -363,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 30.34M 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap DeferredRentCreditNoncurrent Deferred Rent Credit, Noncurrent USD 6.59M 2015-03-31 2015 Q1 10-Q 2015-05-07 0001193125-15-175829
us-gaap DeferredRevenue Deferred Revenue USD 3.30M 2017-12-31 2017 FY 10-K 2018-03-01 0001564590-18-004107
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 3.30M 2018-09-30 2018 Q3 10-Q 2018-10-31 0001564590-18-025831
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap DeferredTaxAssetsCapitalLossCarryforwards Deferred Tax Assets, Capital Loss Carryforwards USD 0 2012-12-31 2012 FY 10-K 2013-03-15 0001193125-13-109941
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 1.14B 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 411.50M 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap DeferredTaxAssetsInventory Deferred Tax Assets, Inventory USD 30.21M 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 2.82M 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 0 2016-12-31 2016 FY 10-K 2017-02-28 0001564590-17-002842
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 96.59M 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 49.43M 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax Deferred Tax Assets, Tax Credit Carryforwards, Alternative Minimum Tax USD 3.37M 2019-12-31 2019 FY 10-K 2020-02-26 0001564590-20-006769
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits USD 91.72M 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 1.03B 2026-03-31 2026 Q1 10-Q 2026-05-06 0001193125-26-208893
us-gaap DefinedContributionPlanCostRecognized Defined Contribution Plan, Cost USD 9.40M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage Defined Contribution Plan, Employers Matching Contribution, Annual Vesting Percentage pure 1 2015-01-01 2015-12-31 2023 FY 10-K 2024-02-28 0000950170-24-022036
us-gaap DepositsAssetsCurrent Deposits Assets, Current USD 16.78M 2016-09-30 2016 Q3 10-Q 2016-11-07 0001564590-16-027821
us-gaap DepositsAssetsNoncurrent Deposits Assets, Noncurrent USD 82.96M 2019-03-31 2019 Q1 10-Q 2019-05-08 0001564590-19-017175
us-gaap Depreciation Depreciation USD 51.40M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 26.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap DerivativeAssetsCurrent Derivative Asset, Current USD 44.62M 2024-09-30 2024 Q3 10-Q 2024-11-06 0000950170-24-122239
us-gaap DerivativeLiabilitiesCurrent Derivative Liability, Current USD 9.01M 2013-12-31 2014 FY 10-K 2015-02-26 0001193125-15-063997
us-gaap DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) USD 571.51M 2014-03-31 2014 Q1 10-Q 2014-05-08 0001193125-14-188608
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares 2.82 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -1.2 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-04 0000950170-22-007375
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares 2.78 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure -0.016 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-28 0000950170-25-029973
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure 0.022 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-28 0000950170-25-029973
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure -0.072 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-28 0000950170-25-029973
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure 0.061 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-28 0000950170-25-029973
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0.007 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-28 0000950170-25-029973
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure -0.005 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-28 0000950170-25-029973
us-gaap EffectiveIncomeTaxRateReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Percent pure 0.057 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure 0.015 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-28 0001564590-17-002842
us-gaap EmployeeBenefitsAndShareBasedCompensation Employee Benefits and Share-based Compensation USD 26.30M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-28 0000950170-24-022036
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 45.81M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount Share-based Payment Arrangement, Amount Capitalized USD -11.38M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 218.00M 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap EquityMethodInvestmentOtherThanTemporaryImpairment Equity Method Investment, Other than Temporary Impairment USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-28 0001564590-17-002842
us-gaap FairValueAssumptionsExpectedDividendRate Fair Value Assumptions, Expected Dividend Rate (Deprecated 2018-01-31) pure 0 2014-01-01 2014-06-30 2014 Q2 10-Q 2014-08-07 0001193125-14-299374
us-gaap FairValueAssumptionsRiskFreeInterestRate Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) pure 0.001 2014-01-01 2014-03-31 2014 Q1 10-Q 2014-05-08 0001193125-14-188608
us-gaap FederalIncomeTaxExpenseBenefitContinuingOperations Federal Income Tax Expense (Benefit), Continuing Operations USD -1.27M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap FinancingReceivableAllowanceForCreditLossesWriteOffs Financing Receivable, Allowance for Credit Loss, Writeoff USD 0 2013-01-01 2013-09-30 2013 Q3 10-Q 2013-11-12 0001193125-13-436840
us-gaap FinancingReceivableRecordedInvestmentCurrent Financing Receivable, Not Past Due USD 20.00M 2019-06-30 2019 Q2 10-Q 2019-08-07 0001564590-19-030035
us-gaap FiniteLivedIntangibleAssetsAccumulatedAmortization Finite-Lived Intangible Assets, Accumulated Amortization USD 13.89M 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive Finite-Lived Intangible Asset, Expected Amortization, after Year Five USD 15.85M 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths Finite-Lived Intangible Asset, Expected Amortization, Year One USD 2.85M 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFive Finite-Lived Intangible Asset, Expected Amortization, Year Five USD 2.31M 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFour Finite-Lived Intangible Asset, Expected Amortization, Year Four USD 2.35M 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearThree Finite-Lived Intangible Asset, Expected Amortization, Year Three USD 2.75M 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo Finite-Lived Intangible Asset, Expected Amortization, Year Two USD 2.83M 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap FiniteLivedIntangibleAssetsGross Finite-Lived Intangible Assets, Gross USD 42.84M 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 29.83M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap FiniteLivedLicenseAgreementsGross Finite-Lived License Agreements, Gross USD 1.00M 2016-09-30 2016 Q3 10-Q 2016-11-07 0001564590-16-027821
us-gaap FiniteLivedPatentsGross Finite-Lived Patents, Gross USD 10.16M 2016-09-30 2016 Q3 10-Q 2016-11-07 0001564590-16-027821
us-gaap ForeignIncomeTaxExpenseBenefitContinuingOperations Foreign Income Tax Expense (Benefit), Continuing Operations USD 1.01M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap GainLossOnContractTermination Gain (Loss) on Contract Termination USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap GainLossOnDispositionOfAssets1 Gain (Loss) on Disposition of Assets USD -88,000 2019-01-01 2019-03-31 2019 Q1 10-Q 2019-05-08 0001564590-19-017175
us-gaap GainLossOnDispositionOfIntangibleAssets Gain (Loss) on Disposition of Intangible Assets USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap GainLossOnInvestments Gain (Loss) on Investments USD -2.68M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap GainLossOnSaleOfOtherAssets Gain (Loss) on Disposition of Other Assets USD -322,000 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-02 0000950170-23-037125
us-gaap GainLossOnSaleOfProperties Gain (Loss) on Sale of Properties USD -200,000 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-01 0001564590-17-020808
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 60.81M 2016-01-01 2016-09-30 2016 Q3 10-Q 2016-11-07 0001564590-16-027821
us-gaap GovernmentContractReceivable Government Contract Receivable USD 470,000 2020-12-31 2021 FY 10-K 2022-03-01 0000950170-22-002517
us-gaap GovernmentContractReceivableUnbilledAmounts Government Contract Receivable, Unbilled Amounts USD 4.00M 2015-12-31 2015 FY 10-K 2016-02-25 0001564590-16-013358
us-gaap GrossProfit Gross Profit USD -29.10M 2025-10-01 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap ImpairmentOfInvestments Other than Temporary Impairment Losses, Investments USD 17.00M 1980-07-22 2014-03-31 2014 Q1 10-Q 2014-05-08 0001193125-14-188608
us-gaap ImpairmentOfRealEstate Impairment of Real Estate USD 1.45M 1980-07-22 2014-03-31 2014 Q1 10-Q 2014-05-08 0001193125-14-188608
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -635.70M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD 315.66M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD -66.53M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap IncomeLossFromEquityMethodInvestments Income (Loss) from Equity Method Investments USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 11.86M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap IncomeTaxExaminationInterestAccrued Income Tax Examination, Interest Accrued USD 0 2014-12-31 2014 FY 10-K 2015-02-26 0001193125-15-063997
us-gaap IncomeTaxExaminationPenaltiesAccrued Income Tax Examination, Penalties Accrued USD 0 2014-12-31 2014 FY 10-K 2015-02-26 0001193125-15-063997
us-gaap IncomeTaxExaminationPenaltiesAndInterestAccrued Income Tax Examination, Penalties and Interest Accrued USD 0 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap IncomeTaxExaminationPenaltiesAndInterestExpense Income Tax Examination, Penalties and Interest Expense USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 18.05M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap IncomeTaxPaidFederalAfterRefundReceived IncomeTaxPaidFederalAfterRefundReceived USD 13.08M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap IncomeTaxPaidForeignAfterRefundReceived IncomeTaxPaidForeignAfterRefundReceived USD 1.07M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD -236.56M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD -3.13M 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-05 0001564590-15-009495
us-gaap IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities Increase (Decrease) in Accounts Payable and Other Operating Liabilities USD 21.88M 1980-07-22 2013-12-31 2013 FY 10-K 2014-03-03 0001193125-14-080447
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD -29.05M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets Increase (Decrease) in Accounts Receivable and Other Operating Assets USD 20.96M 2014-01-01 2014-06-30 2014 Q2 10-Q 2014-08-07 0001193125-14-299374
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD -37.33M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-05 0001193125-26-335003
us-gaap IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities USD -26.82M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap IncreaseDecreaseInAssetsHeldForSale Increase (Decrease) in Assets Held-for-sale USD 0 2017-04-01 2017-06-30 2017 Q2 10-Q 2017-08-03 0001564590-17-015393
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD -338.51M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap IncreaseDecreaseInDerivativeLiabilities Increase (Decrease) in Derivative Liabilities USD 11.10M 2025-01-01 2025-09-30 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD -29.79M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD -87.16M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap IncrementalCommonSharesAttributableToCallOptionsAndWarrants Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants shares 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-28 0000950170-24-022036
us-gaap IncrementalCommonSharesAttributableToConversionOfDebtSecurities Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities shares 1.12M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap IncrementalCommonSharesAttributableToShareBasedPaymentArrangements Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements shares 1.08M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap InterestExpense Interest Expense USD 64.84M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap InterestExpenseDebt Interest Expense, Debt USD 34.80M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap InterestOnConvertibleDebtNetOfTax Interest on Convertible Debt, Net of Tax USD 1.86M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 853,000 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-03 0001564590-18-010662
us-gaap InterestPaidCapitalized Interest Paid, Capitalized, Investing Activities USD 99,000 2015-01-01 2015-09-30 2016 Q3 10-Q 2016-11-07 0001564590-16-027821
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 46.94M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap InterestPayableCurrent Interest Payable, Current USD 4.58M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap InterestReceivable Interest Receivable USD 2.99M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap InterestReceivableCurrent Interest Receivable, Current USD 2.73M 2023-12-31 2023 FY 10-K 2024-02-28 0000950170-24-022036
us-gaap InventoryFinishedGoodsNetOfReserves Inventory, Finished Goods, Net of Reserves USD 60.63M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap InventoryNet Inventory, Net USD 876.12M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap InventoryNoncurrent Inventory, Noncurrent USD 200.58M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap InventoryRawMaterialsNetOfReserves Inventory, Raw Materials, Net of Reserves USD 132.26M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap InventoryWorkInProcess Inventory, Work in Process, Gross USD 883.81M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap InventoryWorkInProcessAndRawMaterialsNetOfReserves Inventory, Work in Process and Raw Materials, Net of Reserves USD 258.26M 2023-09-30 2023 Q3 10-Q 2023-11-01 0000950170-23-057414
us-gaap InventoryWorkInProcessNetOfReserves Inventory, Work in Process, Net of Reserves USD 482.17M 2024-09-30 2024 Q3 10-Q 2024-11-06 0000950170-24-122239
us-gaap InventoryWriteDown Inventory Write-down USD 11.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 19.65M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap InvestmentIncomeNet Investment Income, Net USD 9.80M 1980-07-22 2013-09-30 2013 Q3 10-Q 2013-11-12 0001193125-13-436840
us-gaap Investments Investments USD 514.80M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap InvestmentsAndOtherNoncurrentAssets Investments and Other Noncurrent Assets USD 107.29M 2018-12-31 2018 FY 10-K 2019-02-28 0001564590-19-005170
us-gaap InvestmentsFairValueDisclosure Investments, Fair Value Disclosure USD 188.40M 2025-06-30 2025 Q2 10-Q 2025-08-06 0000950170-25-103971
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 7.90M 2018-01-01 2018-12-31 2018 FY 10-K 2019-02-28 0001564590-19-005170
us-gaap LeaseCost Lease, Cost USD 146.39M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 340.31M 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 207.15M 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 27.77M 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 27.12M 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 26.34M 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 26.34M 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 25.60M 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 2.81M 2019-09-30 2019 Q3 10-Q 2019-11-07 0001564590-19-041709
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 129.74M 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap LettersOfCreditOutstandingAmount Letters of Credit Outstanding, Amount USD 10.70M 2015-09-30 2017 FY 10-K 2018-03-01 0001564590-18-004107
us-gaap Liabilities Liabilities USD 1.64B 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 3.17B 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap LiabilitiesCurrent Liabilities, Current USD 656.35M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap LiabilitiesFairValueAdjustment Liabilities, Fair Value Adjustment USD 14.50M 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-06 0001193125-25-269436
us-gaap LiabilitiesFairValueDisclosure Financial and Nonfinancial Liabilities, Fair Value Disclosure USD 47.40M 2024-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap LiabilitiesNoncurrent Liabilities, Noncurrent USD 4.79M 2013-09-30 2013 Q3 10-Q 2013-11-12 0001193125-13-436840
us-gaap LineOfCreditFacilityCommitmentFeePercentage Line of Credit Facility, Commitment Fee Percentage pure 0.018 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-26 0001564590-20-006769
us-gaap LitigationSettlementExpense Litigation Settlement, Expense USD 39.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap LoansPayable Loans Payable USD 29.08M 2017-12-31 2017 FY 10-K 2018-03-01 0001564590-18-004107
us-gaap LoansPayableCurrent Loans Payable, Current USD 6.17M 2017-12-31 2018 FY 10-K 2019-02-28 0001564590-19-005170
us-gaap LongTermDebt Long-term Debt USD 857.36M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap LongTermDebtCurrent Long-term Debt, Current Maturities USD 157.97M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive Long-Term Debt, Maturity, after Year Five USD 631.43M 2025-09-30 2025 Q3 10-Q 2025-11-06 0001193125-25-269436
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths Long-Term Debt, Maturity, Year One USD 41.60M 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive Long-Term Debt, Maturity, Year Five USD 937.07M 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour Long-Term Debt, Maturity, Year Four USD 43.55M 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree Long-Term Debt, Maturity, Year Three USD 43.55M 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo Long-Term Debt, Maturity, Year Two USD 204.14M 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear Long-Term Debt, Maturity, Remainder of Fiscal Year USD 92.35M 2024-09-30 2024 Q3 10-Q 2024-11-06 0000950170-24-122239
us-gaap LongTermDebtNoncurrent Long-term Debt, Excluding Current Maturities USD 1.45M 2015-03-31 2015 Q1 10-Q 2015-05-07 0001193125-15-175829
us-gaap LongTermInvestments Long-term Investments USD 108.81M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap LongTermLoansPayable Loans Payable, Noncurrent USD 699.39M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap LongTermNotesPayable Notes Payable, Noncurrent USD 2.26M 2014-12-31 2015 FY 10-K 2016-02-25 0001564590-16-013358
us-gaap LongTermPurchaseCommitmentAmount Long-term Purchase Commitment, Amount USD 54.70M 2023-01-01 2023-03-31 2024 Q3 10-Q 2024-11-06 0000950170-24-122239
us-gaap LossContingencyDamagesSoughtValue Loss Contingency, Damages Sought, Value USD 4.00M 2014-01-01 2014-03-31 2014 Q1 10-Q 2014-05-08 0001193125-14-188608
us-gaap LossContingencyLossInPeriod Loss Contingency, Loss in Period USD 45.00M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-01 0001564590-21-009835
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 241,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD 7.47M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-03 0001564590-18-010662
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -386.12M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD -14.26M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-03 0001564590-18-010662
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD 54.35M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD -35.67M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-03 0001564590-18-010662
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD 297.61M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap NetIncomeLossAttributableToParentDiluted Net Income (Loss) Attributable to Parent, Diluted USD 43.35M 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-07 0000950170-24-092720
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -713.41M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap NetIncomeLossAvailableToCommonStockholdersDiluted Net Income (Loss) Available to Common Stockholders, Diluted USD 299.47M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 Noncash or Part Noncash Acquisition, Fixed Assets Acquired USD 3.52M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1 Noncash or Part Noncash Acquisition, Intangible Assets Acquired USD 210,000 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-07 0001564590-19-041709
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD -47.02M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap NotesAssumed1 Notes Assumed USD 4.61M 2014-01-01 2014-12-31 2016 FY 10-K 2017-02-28 0001564590-17-002842
us-gaap NotesIssued1 Notes Issued USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap NotesPayableCurrent Notes Payable, Current USD 2.49M 2015-12-31 2016 FY 10-K 2017-02-28 0001564590-17-002842
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap OperatingExpenses Operating Expenses USD 178.34M 2016-01-01 2016-09-30 2016 Q3 10-Q 2016-11-07 0001564590-16-027821
us-gaap OperatingIncomeLoss Operating Income (Loss) USD 362.68M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap OperatingLeaseCost Operating Lease, Cost USD 32.93M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 210.57M 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 11.20M 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 195.66M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap OperatingLeasePayments Operating Lease, Payments USD 35.46M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 117.71M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 66.13M 2018-12-31 2019 FY 10-K 2020-02-26 0001564590-20-006769
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 11.39M 2018-12-31 2019 FY 10-K 2020-02-26 0001564590-20-006769
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 11.13M 2018-12-31 2019 FY 10-K 2020-02-26 0001564590-20-006769
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 10.90M 2018-12-31 2019 FY 10-K 2020-02-26 0001564590-20-006769
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 10.76M 2018-12-31 2019 FY 10-K 2020-02-26 0001564590-20-006769
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 12.56M 2018-12-31 2019 FY 10-K 2020-02-26 0001564590-20-006769
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 9.40M 2018-12-31 2019 FY 10-K 2020-02-26 0001564590-20-006769
us-gaap OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear Operating Leases, Future Minimum Payments, Remainder of Fiscal Year USD 1.83M 2018-09-30 2018 Q3 10-Q 2018-10-31 0001564590-18-025831
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.079 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap OperatingLossCarryforwardsValuationAllowance Operating Loss Carryforwards, Valuation Allowance USD 7.90M 2020-12-31 2020 FY 10-K 2021-03-01 0001564590-21-009835
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 5.04M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap OtherAssetsCurrent Other Assets, Current USD 86.61M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap OtherAssetsMiscellaneousCurrent Other Assets, Miscellaneous, Current USD 4.95M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap OtherAssetsMiscellaneousNoncurrent Other Assets, Miscellaneous, Noncurrent USD 3.33M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 146.79M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Noncontrolling Interest USD -1.02M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD -1.86M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap OtherComprehensiveIncomeLossReclassificationAdjustmentForWritedownOfSecuritiesIncludedInNetIncomeNetOfTax Other Comprehensive Income (Loss), Reclassification Adjustment for Write-down of Securities Included in Net Income, Net of Tax (Deprecated 2013-01-31) USD -17.00M 1980-07-22 2013-03-31 2013 Q1 10-Q 2013-05-09 0001193125-13-211458
us-gaap OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForWritedownOfSecuritiesNetOfTax Other Comprehensive (Income) Loss, Reclassification Adjustment from AOCI for Write-down of Securities, Net of Tax USD 17.00M 1980-07-22 2014-03-31 2014 Q1 10-Q 2014-05-08 0001193125-14-188608
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD -1.86M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap OtherInventoryNoncurrent Other Inventory, Noncurrent USD 162.54M 2022-12-31 2022 FY 10-K 2023-02-28 0000950170-23-005062
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 26.03M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 1.89M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap OtherLoansPayable Other Loans Payable USD 2.32M 2017-09-30 2017 Q3 10-Q 2017-11-01 0001564590-17-020808
us-gaap OtherLongTermDebt Other Long-term Debt USD 30.39M 2017-12-31 2018 FY 10-K 2019-02-28 0001564590-19-005170
us-gaap OtherNoncashExpense Other Noncash Expense USD 690,000 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-26 0001564590-20-006769
us-gaap OtherNoncashIncomeExpense Other Noncash Income (Expense) USD -1.38M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap OtherNonoperatingExpense Other Nonoperating Expense USD 285,000 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-02 0000950170-23-016654
us-gaap OtherNonoperatingIncome Other Nonoperating Income USD 18,000 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-03 0001564590-18-010662
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -47.02M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap OtherNonrecurringIncomeExpense Other Nonrecurring (Income) Expense USD -1.87M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap OtherOperatingIncomeExpenseNet Other Operating Income (Expense), Net USD -17.77M 2020-10-01 2020-12-31 2020 FY 10-K 2021-03-01 0001564590-21-009835
us-gaap OtherPrepaidExpenseCurrent Other Prepaid Expense, Current USD 3.67M 2018-12-31 2018 FY 10-K 2019-02-28 0001564590-19-005170
us-gaap PaymentsForRepurchaseOfCommonStock Payments for Repurchase of Common Stock USD 25.01M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap PaymentsForRestructuring Payments for Restructuring USD 711,000 2018-01-01 2018-12-31 2018 FY 10-K 2019-02-28 0001564590-19-005170
us-gaap PaymentsForTenantImprovements Payments for Tenant Improvements USD 153,000 2014-01-01 2014-12-31 2015 FY 10-K 2016-02-25 0001564590-16-013358
us-gaap PaymentsOfDebtExtinguishmentCosts Payment for Debt Extinguishment or Debt Prepayment Cost USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-28 0000950170-25-029973
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap PaymentsToAcquireAvailableForSaleSecurities Payments to Acquire Available-for-sale Securities USD 651.39M 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-10-31 0001564590-18-025831
us-gaap PaymentsToAcquireAvailableForSaleSecuritiesDebt Payments to Acquire Debt Securities, Available-for-sale USD 170.20M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-06 0001193125-26-208893
us-gaap PaymentsToAcquireBusinessesNetOfCashAcquired Payments to Acquire Businesses, Net of Cash Acquired USD 172.56M 2019-01-01 2019-12-31 2021 FY 10-K 2022-03-01 0000950170-22-002517
us-gaap PaymentsToAcquireIntangibleAssets Payments to Acquire Intangible Assets USD 4.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap PaymentsToAcquireInvestments Payments to Acquire Investments USD 557.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 112.99M 1980-07-22 2013-12-31 2013 FY 10-K 2014-03-03 0001193125-14-080447
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 5.57M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap PaymentsToAcquireRestrictedCertificatesOfDeposit Payments to Acquire Restricted Certificates of Deposit USD 10.70M 2015-09-01 2015-09-30 2017 FY 10-K 2018-03-01 0001564590-18-004107
us-gaap PaymentsToAcquireRestrictedInvestments Payments to Acquire Restricted Investments USD 353,000 2018-01-01 2018-12-31 2019 FY 10-K 2020-02-26 0001564590-20-006769
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 3.33M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 1.82M 2017-03-31 2017 Q1 10-Q 2017-05-04 0001564590-17-008747
us-gaap PrepaidExpenseCurrentAndNoncurrent Prepaid Expense USD 2.73M 2023-12-31 2023 FY 10-K 2024-02-28 0000950170-24-022036
us-gaap PrepaidExpenseNoncurrent Prepaid Expense, Noncurrent USD 2.13M 2023-12-31 2023 FY 10-K 2024-02-28 0000950170-24-022036
us-gaap PrepaidInsurance Prepaid Insurance USD 2.09M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap PrepaidTaxes Prepaid Taxes USD 1.00M 2022-12-31 2022 FY 10-K 2023-02-28 0000950170-23-005062
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 570.00M 2017-01-01 2017-12-31 2019 FY 10-K 2020-02-26 0001564590-20-006769
us-gaap ProceedsFromDebtNetOfIssuanceCosts Proceeds from Debt, Net of Issuance Costs USD 29.62M 2017-01-01 2017-09-30 2018 Q3 10-Q 2018-10-31 0001564590-18-025831
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap ProceedsFromIssuanceOfLongTermDebt Proceeds from Issuance of Long-term Debt USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-28 0000950170-23-005062
us-gaap ProceedsFromIssuanceOfWarrants Proceeds from Issuance of Warrants USD 17.10M 2013-01-01 2013-09-30 2013 Q3 10-Q 2013-11-12 0001193125-13-436840
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 19.39M 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-07 0001564590-19-030035
us-gaap ProceedsFromLinesOfCredit Proceeds from Lines of Credit USD 425.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap ProceedsFromLongTermLinesOfCredit Proceeds from Long-term Lines of Credit USD 235.87M 2018-01-01 2018-12-31 2020 FY 10-K 2021-03-01 0001564590-21-009835
us-gaap ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale USD 249.24M 2018-01-01 2018-06-30 2018 Q2 10-Q 2018-08-08 0001564590-18-020534
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-28 0000950170-25-029973
us-gaap ProceedsFromPaymentsForOtherFinancingActivities Proceeds from (Payments for) Other Financing Activities USD -226,000 2013-01-01 2013-12-31 2015 FY 10-K 2016-02-25 0001564590-16-013358
us-gaap ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities Proceeds from Sale and Maturity of Debt Securities, Available-for-sale USD 180.95M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 117.72M 1980-07-22 2013-12-31 2013 FY 10-K 2014-03-03 0001193125-14-080447
us-gaap ProceedsFromSaleOfAvailableForSaleSecurities Proceeds from Sale of Available-for-sale Securities USD 20.00M 2019-01-01 2019-06-30 2020 Q2 10-Q 2020-08-05 0001564590-20-036794
us-gaap ProceedsFromSaleOfIntangibleAssets Proceeds from Sale of Intangible Assets USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap ProceedsFromSaleOfInvestmentProjects Proceeds from Sale of Investment Projects USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap ProceedsFromSaleOfPropertyHeldForSale Proceeds from Sale of Property Held-for-sale USD 1.50M 2017-08-01 2017-08-31 2018 Q1 10-Q 2018-05-03 0001564590-18-010662
us-gaap ProceedsFromSaleOfRestrictedInvestments Proceeds from Sale of Restricted Investments USD 10.70M 2017-01-01 2017-12-31 2019 FY 10-K 2020-02-26 0001564590-20-006769
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 241,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap ProceedsFromStockPlans Proceeds from Stock Plans USD 1.49M 2016-01-01 2016-03-31 2016 Q1 10-Q 2016-05-05 0001564590-16-017783
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD 297.61M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 626.04M 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 319.29M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap PropertyPlantAndEquipmentSalvageValue Property, Plant, and Equipment, Salvage Value USD 17.10M 2017-12-31 2017 FY 10-K 2018-03-01 0001564590-18-004107
us-gaap PurchaseCommitmentRemainingMinimumAmountCommitted Purchase Commitment, Remaining Minimum Amount Committed USD 15.10M 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap PurchaseObligation Purchase Obligation USD 10.40M 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap RepaymentsOfDebt Repayments of Debt USD 1.26M 2018-01-01 2018-12-31 2020 FY 10-K 2021-03-01 0001564590-21-009835
us-gaap RepaymentsOfLinesOfCredit Repayments of Lines of Credit USD 425.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap RepaymentsOfLongTermCapitalLeaseObligations Repayments of Long-term Capital Lease Obligations USD 4.30M 2016-01-01 2016-06-30 2016 Q2 10-Q 2016-08-09 0001564590-16-023663
us-gaap RepaymentsOfLongTermDebt Repayments of Long-term Debt USD 5.05M 2017-01-01 2017-06-30 2018 Q2 10-Q 2018-08-08 0001564590-18-020534
us-gaap RepaymentsOfLongTermDebtAndCapitalSecurities Repayment of Long-term Debt, Long-term Lease Obligation, and Capital Security USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-28 0000950170-25-029973
us-gaap RepaymentsOfLongTermLinesOfCredit Repayments of Long-term Lines of Credit USD 235.95M 2018-01-01 2018-12-31 2020 FY 10-K 2021-03-01 0001564590-21-009835
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 207.24M 2020-10-01 2020-12-31 2020 FY 10-K 2021-03-01 0001564590-21-009835
us-gaap ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost Research and Development Expense (Excluding Acquired in Process Cost) USD 327.77M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap ResearchAndDevelopmentInProcess Research and Development in Process USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-01 0000950170-22-002517
us-gaap RestrictedCash Restricted Cash USD 11.10M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap RestrictedCashAndInvestments Restricted Cash and Investments USD 11.13M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap RestrictedCashAndInvestmentsCurrent Restricted Cash and Investments, Current USD 7.25M 2013-12-31 2014 FY 10-K 2015-02-26 0001193125-15-063997
us-gaap RestrictedCashAndInvestmentsNoncurrent Restricted Cash and Investments, Noncurrent USD 19.15M 2023-09-30 2023 Q3 10-Q 2023-11-01 0000950170-23-057414
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 10.13M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap RestrictedInvestments Restricted Investments USD 4.60M 2014-09-30 2014 Q3 10-Q 2014-11-06 0001193125-14-399619
us-gaap RestrictedInvestmentsCurrent Restricted Investments, Current USD 10.70M 2016-12-31 2017 FY 10-K 2018-03-01 0001564590-18-004107
us-gaap RestrictedInvestmentsNoncurrent Restricted Investments, Noncurrent USD 1.00M 2018-12-31 2018 FY 10-K 2019-02-28 0001564590-19-005170
us-gaap RestructuringAndRelatedCostNumberOfPositionsEliminated Restructuring and Related Cost, Number of Positions Eliminated Workforce 500 2025-07-16 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent Restructuring and Related Cost, Number of Positions Eliminated, Period Percent pure 0.36 2025-07-16 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap RestructuringCharges Restructuring Charges USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap RestructuringCosts Restructuring Costs USD 134,000 2025-07-01 2025-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap RestructuringReserve Restructuring Reserve USD 2.93M 2017-12-31 2018 FY 10-K 2019-02-28 0001564590-19-005170
us-gaap RestructuringReserveAcceleratedDepreciation Restructuring and Related Cost, Accelerated Depreciation USD 800,000 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-28 0001564590-17-002842
us-gaap RestructuringReserveAccrualAdjustment1 Restructuring Reserve, Accrual Adjustment USD -2.22M 2018-01-01 2018-12-31 2018 FY 10-K 2019-02-28 0001564590-19-005170
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -4.58B 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer Revenue from Collaborative Arrangement, Excluding Revenue from Contract with Customer USD 530.44M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 982.97M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap Revenues Revenues USD 1.51B 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 155,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap SaleOfStockConsiderationReceivedOnTransaction Sale of Stock, Consideration Received on Transaction USD 20.00M 2025-08-01 2025-08-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap SaleOfStockPricePerShare Sale of Stock, Price Per Share USD/shares 81 2021-10-31 2023 FY 10-K 2024-02-28 0000950170-24-022036
us-gaap SalesRevenueGoodsNet Sales Revenue, Goods, Net (Deprecated 2018-01-31) USD 138.13M 2018-01-01 2018-06-30 2018 Q2 10-Q 2018-08-08 0001564590-18-020534
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 335.16M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap SeveranceCosts Severance Costs (Deprecated 2013-01-31) USD 201,000 2013-01-01 2013-03-31 2013 Q1 10-Q 2013-05-09 0001193125-13-211458
us-gaap SeveranceCosts1 Severance Costs USD 34.90M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 80.61M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage pure 0.25 2026-07-28 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate Share-based Compensation Arrangement by Share-based Payment Award, Discount from Market Price, Purchase Date pure 0.15 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period shares 5.19M 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-06 0001193125-25-269436
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 39.73 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-06 0001193125-25-269436
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.8 2013-01-01 2013-03-31 2013 Q1 10-Q 2013-05-09 0001193125-13-211458
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.007 2013-01-01 2013-03-31 2013 Q1 10-Q 2013-05-09 0001193125-13-211458
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized shares 3.80M 2020-06-30 2021 FY 10-K 2022-03-01 0000950170-22-002517
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 302,000 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 5.78M 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 78.93 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 8.82M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 69,569 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period shares 713,609 2015-01-01 2015-12-31 2015 FY 10-K 2016-02-25 0001564590-16-013358
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price USD/shares 26.78 2015-01-01 2015-12-31 2015 FY 10-K 2016-02-25 0001564590-16-013358
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 2.49M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures shares 2.22M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 488,192 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 10.48 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 399,000 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 6.59M 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 83 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 378,000 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 6.52M 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 82.74 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value (Deprecated 2013-01-31) USD 624,000 2013-01-01 2013-03-31 2013 Q1 10-Q 2013-05-09 0001193125-13-211458
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value USD 4.90M 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-03 0001193125-14-080447
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost Share-based Payment Arrangement, Plan Modification, Incremental Cost USD 82.10M 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-02 0000950170-22-013863
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 49.62 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 32.38 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 76.99 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 93.66 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap SharePrice Share Price USD/shares 29.79 2014-06-30 2014 Q2 10-Q 2014-08-07 0001193125-14-299374
us-gaap ShortTermInvestments Short-term Investments USD 406.02M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap StateAndLocalIncomeTaxExpenseBenefitContinuingOperations State and Local Income Tax Expense (Benefit), Continuing Operations USD 11.44M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 1.53B 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD 336.69M 2016-12-31 2016 FY 10-K 2017-02-28 0001564590-17-002842
us-gaap StockholdersEquityNoteStockSplitConversionRatio Stockholders' Equity Note, Stock Split, Conversion Ratio (Deprecated 2013-01-31) pure 0.167 2012-07-01 2012-07-31 2013 Q1 10-Q 2013-05-09 0001193125-13-211458
us-gaap StockIssued1 Stock Issued USD 20.00M 2025-07-01 2025-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 2.50M 2020-02-01 2020-02-29 2022 FY 10-K 2023-02-28 0000950170-23-005062
us-gaap StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited Stock Issued During Period, Shares, Restricted Stock Award, Forfeited shares 262 2013-01-01 2013-03-31 2013 Q1 10-Q 2013-05-09 0001193125-13-211458
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 225,230 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 25.56M 1980-07-22 2010-12-31 2013 FY 10-K 2014-03-03 0001193125-14-080447
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 1.19M 2025-07-01 2025-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures USD 0 2014-01-01 2014-12-31 2014 FY 10-K 2015-02-26 0001193125-15-063997
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 0 2014-01-01 2014-12-31 2014 FY 10-K 2015-02-26 0001193125-15-063997
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 241,000 2026-01-01 2026-03-31 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap TenantImprovements Tenant Improvements USD 6.20M 2013-12-31 2014 Q1 10-Q 2014-05-08 0001193125-14-188608
us-gaap TradingSecurities Debt Securities, Trading, and Equity Securities, FV-NI USD 617.63M 2017-09-30 2017 Q3 10-Q 2017-11-01 0001564590-17-020808
us-gaap TradingSecuritiesShortTermInvestmentsAmortizedCost Trading Securities, Short-term Investments, Amortized Cost (Deprecated 2018-01-31) USD 617.64M 2017-09-30 2017 Q3 10-Q 2017-11-01 0001564590-17-020808
us-gaap TreasuryStockCommonShares Treasury Stock, Common, Shares shares 655,642 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap TreasuryStockValue Treasury Stock, Value USD 25.01M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap UnamortizedDebtIssuanceExpense Unamortized Debt Issuance Expense USD 918,000 2017-12-31 2017 FY 10-K 2018-03-01 0001564590-18-004107
us-gaap UnbilledReceivablesCurrent Unbilled Receivables, Current USD 929,000 2017-03-31 2017 Q1 10-Q 2017-05-04 0001564590-17-008747
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 67.95M 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions USD 304,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense USD 0 2014-01-01 2014-12-31 2014 FY 10-K 2015-02-26 0001193125-15-063997
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 1.72M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 71.80M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-28 0000950170-24-022036
us-gaap ValuationAllowancesAndReservesBalance SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount USD 169.67M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap ValueAddedTaxReceivable Value Added Tax Receivable USD 13.81M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap VariableLeaseCost Variable Lease, Cost USD 113.45M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-084144
us-gaap WarrantsNotSettleableInCashFairValueDisclosure Warrants Not Settleable in Cash, Fair Value Disclosure USD 9.01M 2013-12-31 2014 FY 10-K 2015-02-26 0001193125-15-063997
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 107.65M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 87,253 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-04 0000950170-22-007375
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 105.45M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449721

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →